NGOs: Mexico risks corn damage if GM maize is planted

Environmentalists are warning that Mexico, the cradle of corn, risks damaging its staple if the government gives US firms the green light to plant genetically-modified maize in huge swaths of land.

How better financing could help create new cancer drugs

The pharmaceuticals industry presents a quandary for potential investors: Major investments in drug development pay off handsomely in a relatively small number of cases, but many other projects deliver no returns at all. ...

Cuba launches first nanopharmaceutical

Cuba has unveiled its first manufactured nanopharmaceutical drug—a tweaked variety of cyclosporine, used to help prevent transplant rejection—official media reported Saturday.

Bugs may be resistant to genetically modified corn

(AP) -- One of the nation's most widely planted crops - a genetically engineered corn plant that makes its own insecticide - may be losing its effectiveness because a major pest appears to be developing resistance more quickly ...

Vatican, biotech firm host adult stem cell meeting

(AP) -- The Vatican has entered into an unusual partnership with a small U.S. biotech company to promote using adult stem cells for treating disease, rather than focusing research on embryonic stem cells.

Europe's first human embryonic stem cell trial approved

A US biotech company said Thursday it will soon begin the first-ever European trials using human embryonic stem cells in an experimental treatment for people with a form of juvenile blindness.

The development of better biotech enzymes

Enzymes are proteins that speed up chemical reactions, such as laundry detergent digesting protein stains, which are otherwise very difficult to remove. A research team led by Professor Kam-bo Wong of the Centre for Protein ...

page 3 from 4